Stock RNXT RENOVORX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. RenovoRx, Inc.

Equities

RNXT

US75989R1077

Market Closed - Nasdaq
Other stock markets
 02:00:00 25/06/2024 am IST 		5-day change 1st Jan Change
1.145 USD +4.09% Intraday chart for RenovoRx, Inc. -15.19% -50.00%
10/06 RenovoRx, Inc. Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships CI
21/05 RenovoRx, Inc. Announces Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Alliance Global Starts RenovoRx With Buy Rating, $4 Price Target
MT
Maxim Downgrades RenovoRx to Hold From Buy
MT
Roth MKM Adjusts Price Target on RenovoRx to $13 From $14, Maintains Buy Rating
MT
Roth Capital Starts RenovoRx at Buy With $16 Price Target
MT
RENOVORX : Maxim Starts RenovoRx at Buy with $15 Price Target
MT
RenovoRx : Files for IPO, Sets Target Price of $11-$13/Unit
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RNXT Stock
  4. News RenovoRx, Inc.
  5. Analyst Reco.